Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Dermatology | Immunology | Musculoskeletal | Rheumatology
Cutaneous Lupus Erythematosus Clinical Trials
A listing of Cutaneous Lupus Erythematosus medical research trials actively recruiting patient volunteers. Use the filters below to narrow your search results.
Filter by:
Phase:
All
N/A
0
1
1/2
2
2/3
3
4
Gender:
Both
Male
Female
Age:
Location:
All
US: Alabama
US: Alaska
US: Arizona
US: Arkansas
US: California
US: Colorado
US: Connecticut
US: Delaware
US: District of Columbia
US: Florida
US: Georgia
US: Hawaii
US: Idaho
US: Illinois
US: Indiana
US: Iowa
US: Kansas
US: Kentucky
US: Louisiana
US: Maine
US: Maryland
US: Massachusetts
US: Michigan
US: Minnesota
US: Mississippi
US: Missouri
US: Montana
US: Nebraska
US: Nevada
US: New Hampshire
US: New Jersey
US: New Mexico
US: New York
US: North Carolina
US: North Dakota
US: Ohio
US: Oklahoma
US: Oregon
US: Pennsylvania
US: Rhode Island
US: South Carolina
US: South Dakota
US: Tennessee
US: Texas
US: Utah
US: Vermont
US: Virgin Islands
US: Virginia
US: Washington
US: West Virginia
US: Wisconsin
US: Wyoming
Afghanistan
Åland Islands
Albania
Algeria
American Samoa
Andorra
Angola
Anguilla
Antarctica
Antigua and Barbuda
Argentina
Armenia
Aruba
Australia
Austria
Azerbaijan
Bahamas
Bahrain
Bangladesh
Barbados
Belarus
Belgium
Belize
Benin
Bermuda
Bhutan
Bolivia
Bosnia and Herzegovina
Botswana
Bouvet Island
Brazil
British Indian Ocean Territory
Brunei Darussalam
Bulgaria
Burkina Faso
Burundi
Cambodia
Cameroon
Canada
Cape Verde
Cayman Islands
Central African Republic
Chad
Chile
China
Christmas Island
Cocos (Keeling) Islands
Colombia
Comoros
Congo
Congo, The Democratic Republic of the
Cook Islands
Costa Rica
Côte D'ivoire
Croatia
Cuba
Cyprus
Czech Republic
Denmark
Djibouti
Dominica
Dominican Republic
Ecuador
Egypt
El Salvador
Equatorial Guinea
Eritrea
Estonia
Ethiopia
Falkland Islands (Malvinas)
Faroe Islands
Fiji
Finland
France
French Guiana
French Polynesia
French Southern Territories
Gabon
Gambia
Georgia
Germany
Ghana
Gibraltar
Greece
Greenland
Grenada
Guadeloupe
Guam
Guatemala
Guernsey
Guinea
Guinea-Bissau
Guyana
Haiti
Heard Island And Mcdonald Islands
Holy See (Vatican City State)
Honduras
Hong Kong
Hungary
Iceland
India
Indonesia
Iran, Islamic Republic of
Iraq
Ireland
Isle Of Man
Israel
Italy
Jamaica
Japan
Jersey
Jordan
Kazakhstan
Kenya
Kiribati
Korea, Democratic People's Republic of
Korea, Republic of
Kuwait
Kyrgyzstan
Lao People's Democratic Republic
Latvia
Lebanon
Lesotho
Liberia
Libyan Arab Jamahiriya
Liechtenstein
Lithuania
Luxembourg
Macao
Macedonia, The Former Yugoslav Republic of
Madagascar
Malawi
Malaysia
Maldives
Mali
Malta
Marshall Islands
Martinique
Mauritania
Mauritius
Mayotte
Mexico
Micronesia, Federated States of
Moldova, Republic of
Monaco
Mongolia
Montenegro
Montserrat
Morocco
Mozambique
Myanmar
Namibia
Nauru
Nepal
Netherlands
Netherlands Antilles
New Caledonia
New Zealand
Nicaragua
Niger
Nigeria
Niue
Norfolk Island
Northern Mariana Islands
Norway
Oman
Pakistan
Palau
Palestinian Territory, Occupied
Panama
Papua New Guinea
Paraguay
Peru
Philippines
Pitcairn
Poland
Portugal
Puerto Rico
Qatar
Réunion
Romania
Russian Federation
Rwanda
Saint Barthélemy
Saint Helena
Saint Kitts And Nevis
Saint Lucia
Saint Martin
Saint Pierre and Miquelon
Saint Vincent and The Grenadines
Samoa
San Marino
Sao Tome And Principe
Saudi Arabia
Senegal
Serbia
Seychelles
Sierra Leone
Singapore
Slovakia
Slovenia
Solomon Islands
Somalia
South Africa
South Georgia and the South Sandwich Islands
Spain
Sri Lanka
Sudan
Suriname
Svalbard And Jan Mayen
Swaziland
Sweden
Switzerland
Syrian Arab Republic
Taiwan, Province of China
Tajikistan
Tanzania, United Republic of
Thailand
Timor-Leste
Togo
Tokelau
Tonga
Trinidad And Tobago
Tunisia
Turkey
Turkmenistan
Turks And Caicos Islands
Tuvalu
Uganda
Ukraine
United Arab Emirates
United Kingdom
United States Minor Outlying Islands
Uruguay
Uzbekistan
Vanuatu
Venezuela
Viet Nam
Virgin Islands, British
Virgin Islands, U.S.
Wallis And Futuna
Western Sahara
Yemen
Zambia
Zimbabwe
First 1 2 Last
Alabama
Pfizer Investigational Site
Anniston Alabama 36207
A clinical trial to evaluate treatments using PD-0360324 and Placebo for patients with Cutaneous Lupus Erythematosus
Pfizer Investigational Site
Oxford Alabama 36203
A clinical trial to evaluate treatments using PD-0360324 and Placebo for patients with Cutaneous Lupus Erythematosus
California
The Institute for Clinical and Translational Science (ICTS)
Irvine California 92697
A clinical trial to evaluate treatments using IVIg for patients with Cutaneous Lupus Erythematosus
Pfizer Investigational Site
Los Angeles California 90045
A clinical trial to evaluate treatments using PD-0360324 and Placebo for patients with Cutaneous Lupus Erythematosus
Research Site
Stanford California 94305
A Phase 1 clinical study for patients with Cutaneous Lupus, Discoid Lupus, Lupus or Systemic Lupus Erythematosus
Florida
Pfizer Investigational Site
Fort Lauderdale Florida 33334
A clinical trial to evaluate treatments using PD-0360324 and Placebo for patients with Cutaneous Lupus Erythematosus
Pfizer Investigational Site
Orange Park Florida 32073
A clinical trial to evaluate treatments using PD-0360324 and Placebo for patients with Cutaneous Lupus Erythematosus
Georgia
Research Site
Atlanta Georgia 30322
A Phase 1 clinical study for patients with Cutaneous Lupus, Discoid Lupus, Lupus or Systemic Lupus Erythematosus
Illinois
Pfizer Investigational Site
Chicago Illinois 60611
A clinical trial to evaluate treatments using PD-0360324 and Placebo for patients with Cutaneous Lupus Erythematosus
Indiana
Pfizer Investigational Site
Indianapolis Indiana 46256
A clinical trial to evaluate treatments using PD-0360324 and Placebo for patients with Cutaneous Lupus Erythematosus
Indianapolis Indiana
Patients are needed to participate in a clinical research study for Lupus Erythematosus, Cutaneous, Lupus Erythematosus, Systemic or Lupus Erythematosus, Discoid
Michigan
Research Site
Ann Arbor Michigan 48103
A Phase 1 clinical study for patients with Cutaneous Lupus, Discoid Lupus, Lupus or Systemic Lupus Erythematosus
New York
Pfizer Investigational Site
Bronx New York 10467
A clinical trial to evaluate treatments using PD-0360324 and Placebo for patients with Cutaneous Lupus Erythematosus
North Carolina
Research Site
Durham North Carolina 27710
A Phase 1 clinical study for patients with Cutaneous Lupus, Discoid Lupus, Lupus or Systemic Lupus Erythematosus
Pennsylvania
Pfizer Investigational Site
Duncansville Pennsylvania 16635
A clinical trial to evaluate treatments using PD-0360324 and Placebo for patients with Cutaneous Lupus Erythematosus
Research Site
Philadelphia Pennsylvania 19104
A Phase 1 clinical study for patients with Cutaneous Lupus, Discoid Lupus, Lupus or Systemic Lupus Erythematosus
Research Site
Philadelphia Pennsylvania 19104
Patients are needed to participate in a clinical research study evaluating AMG 557 and AMG 557 Placebo for the treatment of Cutaneous Lupus or Lupus
Pfizer Investigational Site
Wyomissing Pennsylvania 19610
A clinical trial to evaluate treatments using PD-0360324 and Placebo for patients with Cutaneous Lupus Erythematosus
Tennessee
Pfizer Investigational Site
Jackson Tennessee 38305
A clinical trial to evaluate treatments using PD-0360324 and Placebo for patients with Cutaneous Lupus Erythematosus
Texas
Research Site
Dallas Texas 75231
A Phase 1 clinical study for patients with Cutaneous Lupus, Discoid Lupus, Lupus or Systemic Lupus Erythematosus
Research Site
Dallas Texas 75231
Patients are needed to participate in a clinical research study evaluating AMG 557 and AMG 557 Placebo for the treatment of Cutaneous Lupus or Lupus
Dallas Texas 75231
Patients are needed to participate in a clinical research study evaluating AMG 557 and AMG 557 Placebo for the treatment of Cutaneous Lupus or Lupus
Dallas Texas
Patients are needed to participate in a clinical research study for Lupus Erythematosus, Cutaneous, Lupus Erythematosus, Systemic or Lupus Erythematosus, Discoid
Virginia
Pfizer Investigational Site
Norfolk Virginia 23507
A clinical trial to evaluate treatments using PD-0360324 and Placebo for patients with Cutaneous Lupus Erythematosus
West Virginia
Pfizer Investigational Site
Clarksburg West Virginia 26301
A clinical trial to evaluate treatments using PD-0360324 and Placebo for patients with Cutaneous Lupus Erythematosus
Australia
Research Site
Carlton Victoria 3053
Patients are needed to participate in a clinical research study evaluating AMG 557 and AMG 557 Placebo for the treatment of Cutaneous Lupus or Lupus
Research Site
Woolloongabba Queensland 4102
Patients are needed to participate in a clinical research study evaluating AMG 557 and AMG 557 Placebo for the treatment of Cutaneous Lupus or Lupus
Canada
Pfizer Investigational Site
Markham Ontario L3P 1A8
A clinical trial to evaluate treatments using PD-0360324 and Placebo for patients with Cutaneous Lupus Erythematosus
Germany
Department of Dermatology, University of Leipzig
Leipzig Saxony 04103
A clinical study for patients with Lupus Erythematosus, Cutaneous or Lupus Erythematosus, Discoid
Klinik und Poliklinik für Hautkrankheiten, Universitätsklinikum Münster
Münster 48149
A clinical trial to evaluate treatments using Daylong products for patients with Cutaneous Lupus Erythematosus
Japan
Investigational Site Number 392022
Bunkyo-Ku
A clinical trial seeking patients for a research study for the treatment of Cutaneous Lupus Erythematosus-Systemic Lupus Erythematosus
Investigational Site Number 392017
Bunkyo-Ku
A clinical trial seeking patients for a research study for the treatment of Cutaneous Lupus Erythematosus-Systemic Lupus Erythematosus
Investigational Site Number 392003
Chuo-Ku
A clinical trial seeking patients for a research study for the treatment of Cutaneous Lupus Erythematosus-Systemic Lupus Erythematosus
Investigational Site Number 392011
Chuo-Ku, Kumamoto-Shi
A clinical trial seeking patients for a research study for the treatment of Cutaneous Lupus Erythematosus-Systemic Lupus Erythematosus
Investigational Site Number 392001
Fuchu-Shi
A clinical trial seeking patients for a research study for the treatment of Cutaneous Lupus Erythematosus-Systemic Lupus Erythematosus
View More »
Investigational Site Number 392009
Iruma-Gun
A clinical trial seeking patients for a research study for the treatment of Cutaneous Lupus Erythematosus-Systemic Lupus Erythematosus
Investigational Site Number 392008
Iruma-Gun
A clinical trial seeking patients for a research study for the treatment of Cutaneous Lupus Erythematosus-Systemic Lupus Erythematosus
Investigational Site Number 392005
Itabashi-Ku
A clinical trial seeking patients for a research study for the treatment of Cutaneous Lupus Erythematosus-Systemic Lupus Erythematosus
Investigational Site Number 392014
Kamogawa City
A clinical trial seeking patients for a research study for the treatment of Cutaneous Lupus Erythematosus-Systemic Lupus Erythematosus
Investigational Site Number 392019
Kanazawa-Shi
A clinical trial seeking patients for a research study for the treatment of Cutaneous Lupus Erythematosus-Systemic Lupus Erythematosus
Investigational Site Number 392007
Kitakyushu
A clinical trial seeking patients for a research study for the treatment of Cutaneous Lupus Erythematosus-Systemic Lupus Erythematosus
Investigational Site Number 392020
Maebashi-Shi
A clinical trial seeking patients for a research study for the treatment of Cutaneous Lupus Erythematosus-Systemic Lupus Erythematosus
Investigational Site Number 392012
Nagasaki-Shi
A clinical trial seeking patients for a research study for the treatment of Cutaneous Lupus Erythematosus-Systemic Lupus Erythematosus
Investigational Site Number 392010
Nagoya-Shi
A clinical trial seeking patients for a research study for the treatment of Cutaneous Lupus Erythematosus-Systemic Lupus Erythematosus
Investigational Site Number 392013
Nakagami-Gun
A clinical trial seeking patients for a research study for the treatment of Cutaneous Lupus Erythematosus-Systemic Lupus Erythematosus
Investigational Site Number 392018
Sagamihara-Shi
A clinical trial seeking patients for a research study for the treatment of Cutaneous Lupus Erythematosus-Systemic Lupus Erythematosus
Investigational Site Number 392006
Sagamihara-Shi
A clinical trial seeking patients for a research study for the treatment of Cutaneous Lupus Erythematosus-Systemic Lupus Erythematosus
Investigational Site Number 392002
Shinjuku-Ku
A clinical trial seeking patients for a research study for the treatment of Cutaneous Lupus Erythematosus-Systemic Lupus Erythematosus
Investigational Site Number 392023
Tomigusuku-Shi
A clinical trial seeking patients for a research study for the treatment of Cutaneous Lupus Erythematosus-Systemic Lupus Erythematosus
First 1 2 Last